PT-141 10mg: Proven & Advanced Bremelanotide Research Peptide
PT-141 10mg – Advanced Research Product for Melanocortin Studies
PT-141 10mg, also known as Bremelanotide, is a synthetic cyclic peptide that has attracted substantial scientific interest because of its activity within the melanocortin receptor system.
Unlike research compounds whose principal mechanisms involve direct vascular signalling, PT-141 has been extensively investigated for its interaction with melanocortin receptors and central nervous system pathways. This makes PT-141 particularly relevant to research involving neuroendocrine signalling, behavioural neuroscience, peptide pharmacology and reproductive physiology.
Bremelanotide belongs to a broader class of synthetic melanocortin-related peptides developed to investigate how melanocortin receptors influence physiological and behavioural processes. Scientific research has examined the compound in experimental models involving sexual behaviour, motivation, neuroendocrine communication and central receptor signalling.
Our PT-141 10mg is supplied for laboratory research, analytical testing and scientific investigation. It is not intended for human consumption, veterinary use, diagnosis or therapeutic application.
What Is PT-141 10mg?
PT-141 is the research designation commonly associated with Bremelanotide, a synthetic analogue derived from melanocortin-related peptide research.
Bremelanotide is a cyclic heptapeptide and melanocortin receptor agonist. Scientific and regulatory literature describes activity across multiple melanocortin receptor subtypes rather than exclusive activity at one receptor. FDA pharmacology information identifies activity at MC1R, MC4R, MC3R, MC5R and MC2R, with MC1R and MC4R particularly relevant at therapeutic concentrations.
This broad receptor activity is important when interpreting experimental data because melanocortin receptors are distributed throughout multiple tissues and biological systems.
MC3R and MC4R are especially important within central melanocortin research because both are strongly associated with neural signalling. Reviews of the melanocortin system describe MC3R and MC4R as neural melanocortin receptors with important roles in central physiological regulation.
Consequently, PT-141 research can involve considerably more than reproductive physiology alone.
Researchers may use melanocortin agonists such as PT-141 to investigate receptor activation, intracellular signalling, neuropeptide communication and relationships between central neural circuits and physiological responses.
Understanding Bremelanotide and PT-141
Bremelanotide emerged from a research program focused on melanocortin receptor biology.
Earlier melanocortin analogues demonstrated that modification of naturally occurring melanocortin-related peptides could produce compounds with distinct pharmacological properties. PT-141 subsequently became an important research compound because investigators observed biological effects that could not be explained simply through pigmentation pathways.
This led to extensive investigation into the relationship between melanocortin receptors and central nervous system signalling.
PT-141 is therefore relevant to several interconnected research disciplines:
- Receptor pharmacology
- Neuroendocrinology
- Behavioural neuroscience
- Central nervous system research
- Reproductive physiology
- Peptide pharmacology
- Neuropeptide signalling
- Hypothalamic biology
- Motivational behaviour research
- Melanocortin biology
The compound provides researchers with an experimental tool for examining how melanocortin receptor activation can alter downstream biological signalling.
How PT-141 Research Differs From Vascular Research
One of the most interesting aspects of PT-141 10mg research is the distinction between melanocortin-mediated signalling and conventional vascular mechanisms.
Many compounds historically investigated for sexual physiology primarily influence vascular pathways. PT-141 attracted attention because its pharmacology involves melanocortin receptors, including receptors expressed within the central nervous system.
This does not mean that PT-141 operates independently of every physiological system. Melanocortin signalling is complex and interconnected with numerous neural, endocrine and peripheral pathways.
Instead, the distinction is useful when designing experiments.
Researchers can investigate whether particular biological responses are associated with:
- Central receptor activation
- Hypothalamic signalling
- Neurotransmitter communication
- Melanocortin receptor activation
- Peripheral physiological responses
- Interactions between neural and endocrine systems
This makes PT-141 an interesting compound for comparative pharmacology.
PT-141 and Melanocortin Receptors
The melanocortin receptor family consists of five known receptor subtypes:
- MC1R
- MC2R
- MC3R
- MC4R
- MC5R
Each receptor has a different distribution and biological role.
MC1R is strongly associated with melanocyte biology and pigmentation. MC2R is primarily associated with adrenocorticotropic hormone signalling in the adrenal system. MC3R and MC4R are particularly important within central melanocortin biology, while MC5R has broader peripheral expression.
PT-141 interacts with multiple melanocortin receptors. Consequently, research involving this peptide should consider receptor selectivity, receptor distribution and experimental concentration when interpreting observations.
The central melanocortin system has been studied extensively because melanocortin signalling participates in energy homeostasis, behavioural regulation and neuroendocrine communication.
MC4R and PT-141 Research
MC4R is one of the most extensively studied receptors in connection with PT-141.
MC4R is expressed in several regions of the central nervous system, including hypothalamic structures involved in neuroendocrine regulation.
Research into bremelanotide has proposed that activation of central MC4R-associated pathways may influence neuronal signalling relevant to sexual motivation and behavioural responses.
Importantly, the exact biological mechanisms connecting receptor activation with complex behavioural outcomes remain an active area of investigation.
Research should therefore distinguish between:
- Direct receptor activation
- Downstream intracellular signalling
- Neurotransmitter release
- Neural circuit activity
- Observable behavioural responses
These processes are related but are not interchangeable.
This distinction is particularly important when interpreting preclinical studies.
MC3R and Central Melanocortin Biology
MC3R is another receptor of interest in melanocortin research.
Although MC4R has received considerable attention in studies involving PT-141, MC3R contributes to the wider melanocortin signalling network.
Research into MC3R includes investigations of:
- Energy regulation
- Neuroendocrine signalling
- Central peptide pathways
- Behavioural responses
- Reproductive physiology
- Hypothalamic signalling
The relationship between MC3R and MC4R can also be investigated using selective receptor agonists, antagonists and experimental genetic models.
This allows researchers to separate receptor-specific effects from broader melanocortin activity.
PT-141 and the Central Nervous System
A major reason PT-141 10mg is relevant to neuroscience research is its interaction with melanocortin receptors expressed in the brain.
The central melanocortin system participates in complex communication between neurons, neuropeptides and endocrine pathways.
Researchers have investigated whether melanocortin receptor activation influences:
- Motivation
- Sexual behaviour
- Reward-related signalling
- Neurotransmitter communication
- Hypothalamic activity
- Autonomic signalling
- Neuroendocrine communication
Bremelanotide research has proposed relationships between melanocortin receptor activation and neurotransmitter systems, including dopamine-related signalling. Reviews of the neurobiology of bremelanotide discuss MC4R-containing neural circuits and their possible relationship with excitatory neurotransmitter pathways.
These mechanisms are complex and should not be interpreted as evidence that PT-141 produces a particular outcome in every experimental system.
PT-141 and Behavioural Neuroscience
Behavioural neuroscience investigates how biological processes influence observable behaviour.
PT-141 is particularly interesting in this field because melanocortin signalling connects molecular receptor activity with neural circuits involved in motivation and behavioural responses.
Experimental models may examine:
- Motivational behaviour
- Sexual behaviour
- Social behaviour
- Reward pathways
- Neurotransmitter signalling
- Hypothalamic activity
- Hormonal communication
- Neural receptor activation
Animal studies have contributed substantially to understanding the relationship between melanocortin receptor activation and sexual behaviour. However, animal observations cannot automatically be extrapolated to humans.
For this reason, PT-141 remains an important experimental compound rather than a universal model for human behavioural physiology.
PT-141 and Neuroendocrine Research
The nervous and endocrine systems communicate continuously through interconnected signalling networks.
The hypothalamus is particularly important because it integrates neural signals with endocrine regulation.
Melanocortin receptors within hypothalamic and other central nervous system regions have therefore become important research targets.
PT-141 can be studied in models examining relationships between:
- Neuropeptides
- Hormones
- Hypothalamic neurons
- Melanocortin receptors
- Neurotransmitters
- Reproductive signalling
- Behavioural responses
This makes PT-141 10mg research relevant to neuroendocrinology and peptide signalling studies.
PT-141 and Reproductive Physiology Research
Bremelanotide has been extensively studied in the context of sexual behaviour and reproductive physiology.
Early melanocortin research demonstrated that activation of melanocortin pathways could influence sexual responses in experimental models. Subsequent work investigated bremelanotide and related compounds as potential modulators of sexual function.
Research in this field examines how neural signalling contributes to sexual motivation and behavioural responses.
Importantly, reproductive physiology is not controlled by a single receptor or neurotransmitter. It involves complex interactions among:
- Neural circuits
- Hormonal systems
- Neurotransmitters
- Psychological factors
- Sensory inputs
- Peripheral physiological processes
PT-141 provides researchers with one experimental method for investigating the melanocortin component of this broader network.
PT-141 and Sexual Behaviour Research
Sexual behaviour is one of the most extensively investigated areas associated with bremelanotide.
Preclinical research has examined melanocortin receptor activation in relation to sexual motivation and behavioural responses.
Scientific reviews describe bremelanotide as a melanocortin agonist whose effects have been investigated in both male and female sexual-function models.
These studies are useful for understanding receptor biology and behavioural neuroscience.
However, experimental findings should always be interpreted within the context of the model used.
A receptor response observed in an animal model, cell-based assay or pharmacological experiment does not automatically demonstrate an equivalent outcome in humans.
PT-141 and Neurotransmitter Signalling
Another important area of investigation involves neurotransmitter systems.
Research has proposed that activation of melanocortin receptors may influence downstream neuronal signalling involving neurotransmitters such as dopamine.
Dopamine is involved in numerous biological processes, including:
- Motivation
- Reward
- Learning
- Behaviour
- Movement
- Neuroendocrine regulation
Because dopamine signalling is highly complex, researchers must distinguish between direct receptor effects and downstream changes within interconnected neural networks.
PT-141 research therefore provides an opportunity to investigate how peptide receptor activation can influence broader neuronal communication.
PT-141 and Hypothalamic Research
The hypothalamus is a major regulatory region of the brain.
It contributes to:
- Hormonal regulation
- Appetite and energy balance
- Reproductive physiology
- Stress responses
- Circadian processes
- Autonomic regulation
Several melanocortin receptors are expressed within hypothalamic circuits.
Consequently, PT-141 can be incorporated into experimental studies examining relationships between melanocortin signalling and hypothalamic function.
Researchers may investigate receptor distribution, neuronal activation, signalling pathways and interactions with other neuropeptide systems.
PT-141 in Receptor Pharmacology
Receptor pharmacology focuses on understanding how molecules interact with cellular receptors.
PT-141 is particularly useful as a research compound because its interaction with multiple melanocortin receptor subtypes provides opportunities for pharmacological investigation.
Laboratory studies may examine:
- Receptor affinity
- Receptor activation
- Receptor distribution
- Agonist activity
- Signal transduction
- Concentration-response relationships
- Receptor selectivity
- Downstream signalling
These investigations help researchers understand the pharmacological properties of melanocortin ligands.
PT-141 and Signal Transduction
When an agonist interacts with a receptor, the receptor can initiate intracellular signalling.
Melanocortin receptors belong to the G-protein-coupled receptor family.
Activation can influence intracellular signalling pathways involving second messengers and downstream cellular responses.
For research purposes, scientists may examine:
- Receptor coupling
- Intracellular messenger changes
- Signal amplification
- Gene-expression responses
- Neuronal activation
- Cellular adaptation
Understanding these pathways is important because receptor binding alone does not explain the full biological response.
PT-141 Compared With Other Melanocortin Peptides
PT-141 belongs to a broader family of melanocortin-related research compounds.
Other melanocortin peptides have historically been investigated for different biological properties, including pigmentation and receptor pharmacology.
PT-141 is distinct because its research history has focused strongly on central melanocortin signalling and behavioural physiology.
Comparative studies can therefore help researchers understand how structural modifications affect:
- Receptor affinity
- Receptor selectivity
- Pharmacological activity
- Biological distribution
- Functional responses
Such comparisons are valuable for structure-activity relationship research.
PT-141 and Structure-Activity Research
Synthetic peptide modification is an important area of pharmaceutical and biochemical research.
Small structural changes can significantly influence receptor interactions.
PT-141 is a modified melanocortin-related peptide, and its structure allows researchers to investigate relationships between peptide configuration and receptor activity.
Structure-activity research can explore questions such as:
- Which amino-acid residues influence receptor binding?
- How does peptide cyclization affect stability?
- How does molecular structure influence receptor selectivity?
- Which structural characteristics influence biological activity?
- How do modified peptide analogues compare with endogenous melanocortins?
These questions are relevant to medicinal chemistry and peptide pharmacology.
PT-141 and Alpha-MSH Research
Alpha-melanocyte-stimulating hormone, commonly abbreviated α-MSH, is an endogenous melanocortin peptide.
It interacts with melanocortin receptors and contributes to several physiological signalling processes.
Bremelanotide was developed from melanocortin-related peptide research and is structurally related to this biological family.
Studying PT-141 alongside α-MSH and other melanocortin ligands can help researchers examine differences in receptor activation and downstream signalling.
This comparative approach is valuable for understanding how synthetic peptide analogues behave differently from endogenous ligands.
PT-141 and Melanocortin System Research
The melanocortin system is considerably broader than pigmentation alone.
Modern research recognizes melanocortin signalling as an interconnected network involved in:
- Energy homeostasis
- Neuroendocrine communication
- Reproductive physiology
- Behavioural regulation
- Central nervous system signalling
- Pigmentation
- Adrenal physiology
- Metabolic regulation
Reviews of melanocortin biology describe more than a century of research into melanocortin peptides and their receptors.
PT-141 represents one of the synthetic ligands used to investigate this complex receptor system.
PT-141 and Metabolic Research
Although PT-141 is most commonly associated with behavioural and reproductive research, melanocortin receptor biology also overlaps with metabolic regulation.
MC3R and MC4R are important components of central energy-balance pathways.
Research into the central melanocortin system has therefore examined relationships between melanocortin receptors and:
- Food intake
- Energy expenditure
- Metabolic signalling
- Body-weight regulation
- Hypothalamic pathways
However, PT-141 should not be described as a general metabolic treatment or weight-management compound.
Its relevance to metabolic research primarily comes from the broader biological significance of melanocortin receptor signalling.
PT-141 and Central Peptide Pharmacology
Peptide pharmacology examines how biologically active peptides interact with receptors and signalling systems.
PT-141 is a useful example of how synthetic peptide design can produce compounds with pharmacological properties that differ from naturally occurring peptide hormones.
Researchers studying peptide pharmacology may evaluate:
- Molecular structure
- Receptor interaction
- Pharmacokinetics
- Pharmacodynamics
- Metabolic stability
- Receptor distribution
- Biological activity
This makes PT-141 relevant to both basic research and translational pharmacology.
PT-141 10mg Laboratory Research Applications
A PT-141 10mg research format may be relevant to laboratories investigating melanocortin biology and peptide receptor pharmacology.
Potential research areas include:
Receptor Biology
Investigation of melanocortin receptor activation and receptor subtype behaviour.
Behavioural Neuroscience
Study of relationships between receptor activation and experimental behavioural responses.
Neuroendocrinology
Research into interactions between central melanocortin signalling and endocrine pathways.
Reproductive Physiology
Investigation of melanocortin pathways involved in reproductive and sexual behaviour models.
CNS Pharmacology
Research into central receptor distribution, signalling and downstream neuronal communication.
Peptide Pharmacology
Study of synthetic peptide structure, receptor affinity and biological activity.
Comparative Pharmacology
Comparison of PT-141 with other melanocortin agonists and receptor ligands.
Analytical Research With PT-141
Analytical laboratories may also be interested in PT-141 for compound identification and quality evaluation.
Analytical methods can be used to investigate:
- Peptide identity
- Purity
- Molecular mass
- Degradation products
- Batch consistency
- Chemical stability
- Chromatographic profile
Depending on laboratory requirements, techniques such as HPLC and mass spectrometry may be used for characterization.
Analytical results should always be interpreted alongside appropriate reference standards, validated methods and laboratory quality-control procedures.
PT-141 Purity and Quality Considerations
Research peptides require careful quality evaluation because impurities can interfere with experimental observations.
For PT-141 research, researchers may consider:
- Identity confirmation
- Purity assessment
- Molecular-weight confirmation
- Batch documentation
- Manufacturing consistency
- Storage history
- Container integrity
A high-purity research compound can help reduce experimental variability, although purity alone does not guarantee a particular biological outcome.
Laboratories should use appropriate analytical verification when experimental reproducibility is critical.
Why The 10mg Format Matters
The PT-141 10mg format provides a defined quantity of synthetic peptide for laboratory research.
A clearly specified quantity can be useful for laboratories planning:
- Analytical testing
- Comparative studies
- Receptor research
- Method-development work
- Repeated experimental observations
- Batch comparisons
The actual amount required depends entirely on the validated experimental protocol and analytical method.
The 10mg designation describes the supplied research quantity and should not be interpreted as a recommended human-use amount.
PT-141 Storage and Stability
PT-141 is supplied in lyophilised form for research handling.
Lyophilisation is commonly used for peptide research materials because removal of water can improve stability during appropriate storage.
For unopened material, controlled low-temperature storage is generally appropriate according to the supplier’s validated storage specifications.
For this PT-141 10mg product, unopened material should be stored at approximately -20°C, protected from:
- Moisture
- Excessive heat
- Direct sunlight
- Repeated temperature fluctuations
- Contamination
Laboratories should establish their own validated storage and handling procedures based on the experimental requirements and available stability information.
Handling PT-141 in Laboratory Research
Research peptides should be handled using appropriate laboratory procedures.
Good laboratory practice may include:
- Maintaining clean working conditions
- Minimizing unnecessary exposure to environmental contaminants
- Protecting peptide material from excessive heat and moisture
- Maintaining accurate batch records
- Using appropriate analytical controls
- Following institutional laboratory safety procedures
The appropriate handling process depends on the intended analytical or experimental application.
Research Limitations
Although PT-141 has been extensively investigated, scientific research should not be confused with unrestricted human-use guidance.
Bremelanotide has been evaluated in clinical research and an approved pharmaceutical formulation exists in the United States. The FDA-approved product is a specific pharmaceutical formulation with defined composition, strength and labeling.
A laboratory-supplied PT-141 10mg research vial should not be represented as equivalent to an approved pharmaceutical product.
The formulation, manufacturing controls, sterility, concentration and intended use can differ substantially.
Researchers should therefore evaluate each material according to its certificate of analysis, analytical documentation and intended laboratory application.
What Published Research Says About Bremelanotide
Scientific literature has investigated bremelanotide across preclinical and clinical settings.
Reviews describe its activity as a melanocortin receptor agonist and discuss its development for research and clinical investigation into sexual desire and related physiological processes.
Clinical literature has also characterized its safety profile. Reported adverse events in clinical studies included nausea, flushing and headache, demonstrating why pharmaceutical safety information should not be generalized away when discussing the compound.
For laboratory researchers, these findings are valuable background information but do not substitute for experimental controls or appropriate safety procedures.
PT-141 Research and the Difference Between Mechanism and Outcome
A central principle in pharmacology is the distinction between mechanism and outcome.
Demonstrating that PT-141 activates melanocortin receptors does not automatically establish what will happen in every biological system.
The eventual response can depend on:
- Receptor distribution
- Receptor density
- Experimental model
- Concentration
- Cell type
- Downstream signalling
- Competing pathways
- Species
- Biological state
This is why controlled experiments are essential.
A receptor agonist can produce different effects depending on where the receptor is expressed and which downstream pathways are active.
PT-141 in Comparative Research
Researchers can compare PT-141 with other compounds to better understand melanocortin signalling.
Comparative studies may examine:
- Different receptor agonists
- Receptor-selective ligands
- Endogenous melanocortins
- Synthetic peptide analogues
- Small-molecule melanocortin ligands
These comparisons can reveal differences in receptor affinity, signalling behaviour and biological activity.
Such research contributes to a broader understanding of GPCR pharmacology.
Future Directions in PT-141 Research
Melanocortin receptor research continues to develop.
Future investigations may focus on:
- Receptor-selective compounds
- Central nervous system signalling
- Neural circuit mapping
- Behavioural pharmacology
- Neuroendocrine communication
- Peptide structure-activity relationships
- Receptor bias
- Intracellular signalling
- Melanocortin interactions with other neurotransmitter systems
The wider melanocortin system is also being investigated in metabolic and neurological research.
As analytical technologies improve, researchers can investigate receptor signalling at increasingly precise molecular and cellular levels.
Frequently Asked Questions About PT-141 10mg
What is PT-141 10mg?
PT-141 10mg is a laboratory research product containing a specified quantity of PT-141, also known as Bremelanotide. PT-141 is a synthetic melanocortin receptor agonist studied in receptor pharmacology, neuroscience and neuroendocrine research.
Is PT-141 the same as Bremelanotide?
Yes. PT-141 is the commonly used research designation for Bremelanotide.
What receptors does PT-141 interact with?
Bremelanotide interacts with multiple melanocortin receptor subtypes. FDA pharmacology information describes activity across MC1R, MC4R, MC3R, MC5R and MC2R, with MC1R and MC4R particularly relevant at therapeutic concentrations.
Is PT-141 a peptide?
Yes. Bremelanotide is a synthetic cyclic peptide.
Why is PT-141 studied in neuroscience?
PT-141 interacts with melanocortin receptors expressed within the central nervous system, making it relevant to research into neural signalling, motivation, behaviour and neuroendocrine communication.
Is PT-141 studied for reproductive physiology?
Yes. Bremelanotide has been extensively investigated in relation to melanocortin signalling, sexual behaviour and reproductive physiology.
Is PT-141 primarily a vascular research compound?
No. Its principal scientific interest comes from melanocortin receptor pharmacology and central signalling rather than being classified primarily as a direct vascular-acting compound.
Can PT-141 be used for laboratory receptor research?
PT-141 can be investigated as a research ligand in appropriate laboratory models involving melanocortin receptor pharmacology.
What is the PT-141 10mg format?
It refers to the supplied quantity of PT-141 research material. The quantity should not be interpreted as a human-use dosage.
How should PT-141 be stored?
The unopened lyophilised research material should generally be maintained under controlled low-temperature conditions, with approximately -20°C commonly used for storage, while protecting the material from moisture, heat and direct sunlight.
Is PT-141 approved as a medication?
Bremelanotide has an FDA-approved pharmaceutical formulation for a specific indication in premenopausal women with acquired, generalized hypoactive sexual desire disorder. However, a laboratory research vial is not automatically equivalent to that approved pharmaceutical formulation.
Does PT-141 have established human effects?
Bremelanotide has been studied clinically, but research findings should be interpreted in the context of the specific pharmaceutical formulation, population and study design. A research-grade PT-141 product should not be represented as a treatment.
Is PT-141 intended for human use?
The PT-141 10mg research product described on this page is supplied strictly for laboratory research and analytical purposes. It is not intended for human consumption or veterinary use.
PT-141 10mg Product Specifications
Product Name: PT-141 10mg
Alternative Name: Bremelanotide
Product Type: Synthetic research peptide
Research Category: Melanocortin receptor research
Quantity: 10mg
Physical Form: Lyophilised peptide powder
Primary Research Areas: Melanocortin receptor pharmacology, behavioural neuroscience, neuroendocrine research, reproductive physiology and peptide signalling
Research Status: Laboratory Research Use Only
Human Use: Not intended for human use
Veterinary Use: Not intended for veterinary use
Storage: Approximately -20°C for unopened material, subject to validated supplier and laboratory storage requirements
Why Choose PT-141 10mg for Laboratory Research?
Researchers investigating melanocortin receptor biology require compounds that can support controlled experimental work.
PT-141 is particularly valuable because it sits at the intersection of several research disciplines.
Its pharmacology connects:
- Peptide chemistry
- GPCR biology
- Central nervous system signalling
- Neuroendocrinology
- Behavioural neuroscience
- Reproductive physiology
- Receptor pharmacology
The PT-141 10mg format provides researchers with a defined research quantity suitable for analytical and experimental applications where PT-141 is an appropriate compound of interest.
Final Research Summary
PT-141 10mg, also known as Bremelanotide, is a synthetic cyclic melanocortin receptor agonist with a substantial research history in neuropharmacology, behavioural neuroscience and reproductive physiology.
Its scientific importance comes from its ability to interact with the melanocortin receptor system and provide researchers with an experimental tool for studying central peptide signalling.
Research has examined relationships between melanocortin receptor activation and behavioural, neuroendocrine and reproductive pathways. MC4R has received particular attention because of its central nervous system distribution and proposed involvement in neural circuits associated with sexual function.
At the same time, PT-141 interacts with multiple melanocortin receptor subtypes, meaning that its pharmacology should be considered within the broader melanocortin receptor network rather than being reduced to a single receptor or biological effect.
For laboratory researchers, this makes PT-141 a useful compound for investigating receptor activation, peptide pharmacology, neuroendocrine signalling and behavioural neuroscience.
Our PT-141 10mg is supplied exclusively for laboratory research, analytical testing and scientific investigation.
Research Use Only. Not for human consumption. Not for veterinary use. Not intended to diagnose, treat, cure or prevent any disease or medical condition.
PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg PT-141 10mg
